SEHK:1120

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Arts Optical International Holdings

Executive Summary

Arts Optical International Holdings Limited, an investment holding company, manufactures and trades in prescription frames and sunglasses in Europe, the United States, Asia, and internationally.


Snowflake Analysis

Flawless balance sheet and overvalued.

Share Price & News

How has Arts Optical International Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 1120 has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

1120

0.9%

HK Medical Equipment

1.4%

HK Market


1 Year Return

-53.1%

1120

220.2%

HK Medical Equipment

3.1%

HK Market

Return vs Industry: 1120 underperformed the Hong Kong Medical Equipment industry which returned 204.3% over the past year.

Return vs Market: 1120 underperformed the Hong Kong Market which returned 0.4% over the past year.


Shareholder returns

1120IndustryMarket
7 Day0%0.9%1.4%
30 Day-8.9%-1.7%-0.8%
90 Day-18.0%58.3%8.8%
1 Year-53.1%-53.1%222.2%220.2%7.4%3.1%
3 Year-67.8%-68.8%202.9%194.5%-0.2%-10.9%
5 Year-67.0%-71.9%296.9%278.6%8.9%-9.3%

Price Volatility Vs. Market

How volatile is Arts Optical International Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Arts Optical International Holdings undervalued compared to its fair value and its price relative to the market?

0.35x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate 1120's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate 1120's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: 1120 is unprofitable, so we can't compare its PE Ratio to the HK Medical Equipment industry average.

PE vs Market: 1120 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 1120's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 1120 is good value based on its PB Ratio (0.4x) compared to the HK Medical Equipment industry average (4.6x).


Next Steps

Future Growth

How is Arts Optical International Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

28.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Arts Optical International Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Arts Optical International Holdings performed over the past 5 years?

-12.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 1120 is currently unprofitable.

Growing Profit Margin: 1120 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 1120 is unprofitable, and losses have increased over the past 5 years at a rate of 12.3% per year.

Accelerating Growth: Unable to compare 1120's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 1120 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16%).


Return on Equity

High ROE: 1120 has a negative Return on Equity (-14.19%), as it is currently unprofitable.


Next Steps

Financial Health

How is Arts Optical International Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 1120's short term assets (HK$656.2M) exceed its short term liabilities (HK$408.3M).

Long Term Liabilities: 1120's short term assets (HK$656.2M) exceed its long term liabilities (HK$12.1M).


Debt to Equity History and Analysis

Debt Level: 1120's debt to equity ratio (2.7%) is considered satisfactory.

Reducing Debt: 1120's debt to equity ratio has reduced from 7.8% to 2.7% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable 1120 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: 1120 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 6.7% per year.


Next Steps

Dividend

What is Arts Optical International Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 1120's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 1120's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 1120's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 1120's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: 1120 is not paying a notable dividend for the Hong Kong market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 1120's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

15.9yrs

Average board tenure


CEO

Arts Optical International Holdings has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Hoi Ying Ng
Founder & Executive Chairmanno dataHK$1.63m45.59%
HK$ 144.4m
Kim Ying Ng
Executive Directorno dataHK$476.00k7.28%
HK$ 23.1m
Chi Wai Wong
Independent Non-Executive Director15.92yrsHK$144.00kno data
Yu Lung Lam
Independent Non-Executive Director8.92yrsHK$144.00kno data
Hil Lan Chung
Independent Non-Executive Director15.92yrsHK$144.00kno data

15.9yrs

Average Tenure

56yo

Average Age

Experienced Board: 1120's board of directors are seasoned and experienced ( 15.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Arts Optical International Holdings Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Arts Optical International Holdings Limited
  • Ticker: 1120
  • Exchange: SEHK
  • Founded: 1973
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: HK$316.736m
  • Shares outstanding: 386.26m
  • Website: https://www.artsgroup.com

Number of Employees


Location

  • Arts Optical International Holdings Limited
  • Sunbeam Centre
  • 3rd Floor
  • Kwun Tong
  • Kowloon
  • Hong Kong

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
1120SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDNov 1996

Biography

Arts Optical International Holdings Limited, an investment holding company, manufactures and trades in prescription frames and sunglasses in Europe, the United States, Asia, and internationally. The compan ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/08/03 12:51
End of Day Share Price2020/07/31 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.